Announcement of the FDA Regarding the Criteria, Procedures, and Conditions for Registration of Medical Device Manufacturing Facilities (2026)
A seemingly “ordinary” title, but a regulatory shift
On 15 January 2026, the Thai Food and Drug Administration (Thai FDA) issued a new Announcement on the Criteria, Procedures, and Conditions for Registration of Medical Device Manufacturing Facilities, published in the Royal Gazette on 2 March 2026 and effective from May 2026. At first glance, the document may appear to be a routine update of forms required for Medical Device Manufacturing License applications. However, for professionals who follow daily operations in the FDA departments, the implications are substantial and structural.
The announcement fundamentally changes how the Thai FDA evaluates and grants licenses to medical device manufacturing facilities, shifting the focus from a simple document checklist to alignment between the facility’s operations, its technical capabilities, and the risk class of the products handled.
1. Differentiation at the initial screening: type of operation
One of the main changes introduced by the new Announcement concerns the first screening based on the type of operation (rather than simply the license category):
- Manufacturing: full device production process.
- Assembly: assembly of finished components.
- Repacking: repackaging or reassembly without technical modification.
- Sterilization: final sterilization process for devices requiring this treatment.
This categorization ensures that each facility is explicitly authorized for the specific operations it performs, reducing the ambiguities that previously arose when generic “manufacturing” claims did not reflect actual use.
Practically, the Thai FDA now expects SOPs tailored to the activity performed: if the facility assembles devices, SOPs must describe assembly processes; if sterilizing, SOPs must detail sterilization and quality control. This approach minimizes the risk of objections or requests for additional documentation during inspections.
2. Alignment between facility and product risk class
Another key change is how the FDA now links the facility to the risk classification of the products. Previously, evaluations focused primarily on the finished product and its risk class for registration purposes.
Under the new framework, the assessment considers:
- the risk class of the devices handled by the facility,
- the technical capabilities and infrastructure of the facility,
- the quality and appropriateness of documented processes.
This means that a facility producing high-risk devices (Class 3 or Class 4) will face higher operational and quality management requirements than one performing low-risk assembly or repacking.
In practice, this translates to:
- SOPs specific to the operation and product risk,
- facility layouts and equipment appropriate to the declared activity,
- process and quality control records aligned with product risk.
This structure eliminates grey areas where declared operations did not match actual practices—a common cause of inspection delays or deficiencies.
3. Transition for already licensed facilities
It is important to note that facilities already holding a license will continue to operate under the previous rules. However:
- Upon license renewal,
- When modifying the declared operations,
- Or during a scheduled FDA inspection,
the facility must comply with the new criteria, procedures, and conditions, including SOPs that reflect the actual activity and quality control measures proportional to the risk of the products handled.
Practical implications for operators
This Announcement is not a mere formal update. It represents a rationalization of facility evaluation, combining:
- the actual operations performed,
- the technical capabilities of the facility,
- alignment with the risk classification of medical devices handled.
In essence, the Thai FDA is moving toward a more integrated and qualitative assessment, consistent with international best practices in quality management and GMP compliance.


qb4i5w
Golo789gamedownload, downloading games ain’t always my jam, but this was fairly painless. Once installed, experience was pretty good overall. See for yourself: golo789gamedownload
oy5m88
mfv73a
ny3q2a
gdc4cl
c571n5
EE88, cái tên nghe quen quen, hình như có thằng bạn hay chơi ở đây thì phải. Thấy nó bảo nạp rút nhanh lắm. Ai confirm cái nào! Get the scoop here: ee88.
Heard about thmn9 from a buddy – legit site! Easy to navigate and got some good wins early on. Definitely worth checking out for a fun time. thmn9
aspz5a
t9c8sc
The shift from a generic manufacturing category to explicit operations like assembly, repacking, and sterilization is a meaningful change—especially with SOPs tied to each activity and product risk class. Reference2Video could help teams turn reference materials into clear visual training or process-overview videos, while keeping regulatory review
ai reference to video
The shift from generic manufacturing claims to activity-specific authorization is a significant change, especially with the May 2026 effective date. The article’s point about matching SOPs and facility capabilities to each device’s risk class is useful for teams preparing their applications.
wow forever talent
The shift from a generic manufacturing label to activity-specific SOPs—and matching facility capabilities to device risk class—makes the 2026 changes especially significant. Motion Transfer is far removed from licensing, but its portrait-and-reference-video workflow is a useful reminder that precise inputs and clearly defined processes matter.
motion transfer video generator
The shift from a generic manufacturing label to distinct operations like assembly, repacking, and sterilization is a significant practical change, especially when SOPs must match the facility’s actual work and product risk. A short visual walkthrough could help teams explain those process differences clearly.
Burning Bridges AI video generator
The shift from a generic manufacturing label to clearly distinguishing production, assembly, repacking, and sterilization makes the new rules much more practical. I also appreciate the focus on matching SOPs and facility capabilities to product risk class. For training teams on a fixed procedure, a tool like Bulin 47 AI could turn a character photo
Bulin 47 AI Video Generator
you gotta try Drake burning bridges ai video at https://burningbridgesmv.org/. Thats really interesting
The lead time until May 2026 seems reasonable on paper, but getting facility layouts, SOP documentation, and risk alignments sorted for Thai FDA submissions usually eats up a lot more runway than teams expect.
When we were putting together draft equipment diagrams and bilingual packaging mockups for an internal filing review last month, GPT Image 2.5—the image editing tool I’ve been using—let me adjust specific labels on the device packaging without throwing off the rest of the layout. It took two tries to get the secondary text rendered clearly, but it was handy for getting clean visuals into our draft documentation without starting from scratch.
The transition timeline leading up to May 2026 is going to be tight for smaller operators trying to get their cleanroom SOPs and risk classifications properly aligned before Thai FDA inspections start.
We’ve been updating our internal training materials to cover the procedural shifts, and to avoid halting the floor for basic b-roll, I used Kling 4.0 to generate a few filler clips of sterile glove donning using end-frame matching from our actual facility photos. It takes a couple of reruns to keep the latex texture from looking too glossy, but it works fine for standard procedure decks.
A useful guide to Thailand’s medical device manufacturing license requirements for 2026! Clear documentation is essential, and removing halftone dots from scanned photos can improve the readability of older printed materials.
This guide makes the licensing steps much easier to follow, especially for teams preparing their documentation. I also found the ai effects api useful for making clear visual explainers for internal training.
Your Thai FDA licensing timeline is useful, especially the manufacturing license steps for 2026. One small addition worth noting: teams using VR for training or equipment demos often pair it with reference wikis like gilla vr to keep Quest setup and gameplay guides handy. Clearance first, then hardware.